Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
Eligible age
50–99 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is formative evaluation trial guided by the Values Clarification Theory25 and the Cultural Values Theory26, with specific aims to: Aim 1. Develop a culturally appropriate version of the PPC Approach for older AAs with CVCs by assembling a community advisory group of 3 primary care clinicians, 3 older AA patients with CVCs, and 3 AA persons who care for AA patients with CVCs to solicit feedback on the PPC Approach. Aim 2. Determine the acceptability (e.g., program appraisal interviews) and feasibility (e.g., avg. length of program sessions, program participation rate, study completion rate) of the PPC Approach among a sample 20 of under-resourced older southern AA patients with CVCs receiving primary care at Cooper Green Mercy Health Services Authority. Aim 3. Examine the ability of participants to complete pre- and post-test (8 weeks post-baseline) measures of perception of care, treatment burden, shared decision-making, and patient-clinician communication exchange.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ greater than or equal to 50 years old
- ✓ at least one CVD (i.e., coronary artery disease, hypertension, heart failure, arrhythmias, cardiomyopathy, peripheral artery disease, stroke, and valvular heart disease)
- ✓ at least one coexisting chronic condition (i.e., inflammatory joint disease, COPD/asthma, diabetes, chronic kidney disease, and cancer one-year post-treatment)
- ✓ a caregiver of a participant, or a provider who serves this population.
You may not qualify if…
- ✕ Axis I psychiatric (schizophrenia, bipolar disorder), dementia, suicidal ideation,
- ✕ active substance use disorder nursing home or assisted living facility residence.
Where it's recruiting
Birmingham
Source: ClinicalTrials.gov · NCT07748858 · last updated 2026-08-06